Metraipolis › archive › dc_f795d8f4bb80
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges — Europe PMC PMID:33374391
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33374391
- DOI
- 10.3390/pharmaceutics13010024
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:49:02.093Z
- SHA-256 of the archived text
1b7d8516c3d58106c989ea4fcee5120ff6e5b8b712b75e05db044ec4499353ad- Stable URL of this page
https://metraipolis.com/documento/dc_f795d8f4bb80
How to cite
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges — Europe PMC PMID:33374391 — Europe PMC (en), https://europepmc.org/article/MED/33374391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f795d8f4bb80 (Metraipolis archive dc_f795d8f4bb80, sha256 1b7d8516c3d58106c989ea4fcee5120ff6e5b8b712b75e05db044ec4499353ad)
BibTeX
@misc{dcf795d8f4bb80,
title = {Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges — Europe PMC PMID:33374391},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33374391},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f795d8f4bb80; sha256 1b7d8516c3d58106c989ea4fcee5120ff6e5b8b712b75e05db044ec4499353ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33374391. Agents can read the archived copy with the MCP tool read_document.